Intranasal chitosan-g-HPβCD nanoparticles of efavirenz for the CNS targeting
Source abstract
Abstract
Incompetence of antiretrovirals (ARV) in complete eradication of HIV from the CNS is the biggest issue in neuro-AIDS treatment. The ineffectiveness is largely due to the poor penetration of ARV. Hence, the present study is attempted to enhance the CNS uptake of efavirenz (EFV) by designing intranasal EFV nanoparticles (EFV-NPs). EFV-NPs were fabricated using chitosan-g-HPβCD by ionic gelation method and optimized using quadratic response surface methodology (RSM) employing two-factor, five-level circumscribed central composite design. NPs containing drug: polymer ratio (1.25:0.79) were spherical with 198 ± 4.4 nm size, 23.28 ± 1.5% drug loading and 38 ± 1.43% entrapment efficiency. NPs showed sustained drug release (99.03 ± 0.30% in 8 h) and followed Fickian diffusion mechanism. It gave 4.76 times greater permeability than plain drug solution through porcine nasal mucosa. Enhanced CNS bioavailability (12.40-fold that of i.v solution) of EFV, high drug-targeting percentage (99.24%) and drug-targeting index (141.3) post-intranasal administration of NPs was observed. These results are corroborated by gamma scintigraphy images, which revealed high CNS uptake. NPs appeared histocompatible with porcine nasal mucosa and non-toxic to L929 cell line. Thus, CS-g-HPβCD served as a potential carrier in developing intranasal mucoadhesive EFV-NPs for the CNS targeting.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced Drug Delivery Systems · HIV Research and Treatment · Drug Solubulity and Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmaceutics, Institute of Pharmaceutical Education and Research, Wardha, Maharashtra, India;
Rashtrasant Tukdoji Maharaj Nagpur University, Nagpur, Maharashtra, India
Funding
Department of Science and Technology · Department of Science and Technology, Ministry of Science and Technology
References (34)
Show source-provided references
1. Fact sheet. 2016 UNAIDS. Available from: http://www.unaids.org/en/resources/fact-sheet.
2. 10.1016/j.addr.2016.02.00810.1016/j.addr.2016.02.008 ↗
3. 10.1007/s13346-016-029310.1007/s13346-016-0293 ↗
4. 10.1016/S0928-0987(00)00087-710.1016/S0928-0987(00)00087-7 ↗
5. 10.1007/s11481-006-9039-x10.1007/s11481-006-9039-x ↗
6. 10.3109/1061186090348339610.3109/10611860903483396 ↗
7. 10.1166/jnn.2015.918010.1166/jnn.2015.9180 ↗
8. 10.1016/j.antiviral.2015.09.01310.1016/j.antiviral.2015.09.013 ↗
9. 10.3109/10717544.2013.83801410.3109/10717544.2013.838014 ↗
10. 10.2217/nnm.12.10410.2217/nnm.12.104 ↗
11. 10.1016/j.ijpharm.2009.06.01910.1016/j.ijpharm.2009.06.019 ↗
12. 10.1097/00002030-200106150-0002310.1097/00002030-200106150-00023 ↗
13. 10.1016/j.carbpol.2005.08.05110.1016/j.carbpol.2005.08.051 ↗
14. 10.1517/17425247.2.1.33510.1517/17425247.2.1.335 ↗
15. 10.1002/mabi.20050008710.1002/mabi.200500087 ↗
16. Belgamwar AV, Khan SA, Yeole PG. The Patent Office Journal, 3445/MUM/2015A. 2015.
17. 10.1016/j.ijpharm.2005.03.02710.1016/j.ijpharm.2005.03.027 ↗
18. 10.3109/1061186090338693810.3109/10611860903386938 ↗
19. 10.1016/S0928-0987(98)00023-210.1016/S0928-0987(98)00023-2 ↗
20. 10.4103/0250-474X.11060810.4103/0250-474X.110608 ↗
21. Khan SA · Pharmazie · 2008 · 63 · 348
22. Dolly A
23. 10.1016/S0165-0270(02)00033-X10.1016/S0165-0270(02)00033-X ↗
24. Zarghami A, Pandamooz SA, Naji M, Pourghasem M. Modified method for cerebrospinal fluid collection in anesthetized rat and evaluation of the efficacy. 2013;2:97–98.
25. 10.1016/S0378-4347(99)00336-910.1016/S0378-4347(99)00336-9 ↗
26. 10.5897/AJPP11.52510.5897/AJPP11.525 ↗
27. Chawla R · Expert Opin Drug Deliv · 2013 · 10 · 11
28. 10.1016/j.ijpharm.2013.02.02410.1016/j.ijpharm.2013.02.024 ↗
29. 10.1016/j.carbpol.03.06010.1016/j.carbpol.03.060 ↗
30. 10.1016/j.addr.2005.07.00110.1016/j.addr.2005.07.001 ↗
31. Talegaonkar S · I J Pharm · 2004 · 36 · 140
32. 10.1093/jac/dkl47410.1093/jac/dkl474 ↗
33. 10.1128/AAC.06311-1110.1128/AAC.06311-11 ↗
34. 10.1093/jac/dkq43410.1093/jac/dkq434 ↗